| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.39B | 12.72B | 9.26B | 10.86B | 10.94B | 11.83B |
| Gross Profit | 7.91B | 6.67B | 4.23B | 3.83B | 5.50B | 5.53B |
| EBITDA | 5.09B | 4.63B | 3.57B | 3.49B | -6.99B | 397.15M |
| Net Income | 6.20B | 1.21B | 1.16B | 2.25B | -7.37B | -2.14B |
Balance Sheet | ||||||
| Total Assets | 102.31B | 132.56B | 111.21B | 91.22B | 96.61B | 100.84B |
| Cash, Cash Equivalents and Short-Term Investments | 3.63B | 9.02B | 14.44B | 10.75B | 4.36B | 17.23B |
| Total Debt | 57.09B | 69.16B | 75.72B | 56.48B | 62.23B | 60.08B |
| Total Liabilities | 62.37B | 96.20B | 78.85B | 60.11B | 67.32B | 63.86B |
| Stockholders Equity | 39.95B | 36.35B | 32.35B | 31.12B | 29.29B | 36.98B |
Cash Flow | ||||||
| Free Cash Flow | -2.47B | -10.83B | -22.22B | 8.80B | -16.00B | 10.58B |
| Operating Cash Flow | -2.43B | -10.61B | -22.08B | 8.99B | -15.64B | 10.68B |
| Investing Cash Flow | 14.43B | -3.05B | 6.83B | -2.59B | 11.65B | -9.92B |
| Financing Cash Flow | -12.57B | 10.70B | 19.59B | -5.40B | 2.00B | 352.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹48.63B | 16.05 | ― | ― | 14.44% | -10.84% | |
68 Neutral | ₹27.10B | 10.29 | ― | 0.68% | -25.37% | -48.56% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ₹31.23B | 12.44 | ― | 0.29% | 11.75% | -6.52% | |
64 Neutral | ₹53.02B | 15.92 | ― | 0.43% | 24.90% | 11.78% | |
50 Neutral | ₹29.50B | 98.87 | ― | ― | -5.36% | 469.19% |